PD-217,014
id:
pd-217-014-249-4267018
title:
PD-217,014
text:
PD-217,014 is a drug developed by Pfizer and related to gabapentin, which similarly binds to the α2δ calcium channels. It was developed as a potentially more potent successor to gabapentin and pregabalin, along with several other analogues such as atagabalin and 4-methylpregabalin, but while PD-217,014 produces visceral analgesic effects in animal studies with higher potency and efficacy than gabapentin, it was not developed further for clinical use because of its comparatively more complex synt
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/PD-217,014
date created:
date modified:
2024-02-08T14:48:19Z
main entity:
{"identifier":"Q7118738","url":"https://www.wikidata.org/entity/Q7118738"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/99/PD-217%2C014.svg","width":512,"height":456}
fields total:
13
integrity:
15